Temporal effects of cytokine treatment on lubricant synthesis and matrix metalloproteinase activity of fibroblast-like synoviocytes
- PMID: 30403832
- DOI: 10.1002/term.2771
Temporal effects of cytokine treatment on lubricant synthesis and matrix metalloproteinase activity of fibroblast-like synoviocytes
Abstract
Fibroblast-like synoviocytes (FLS) are major contributors to the composition and function of synovial fluid (SF). In disease, changes to important SF molecules such as hyaluronic acid (HA), lubricin, and numerous inflammatory markers contribute to a loss of SF functional properties. Previous studies characterized the ability of FLS to produce SF molecules in short-term cultures using continuous cytokine supplementation. This study assessed the HA, lubricin, and matrix metalloproteinase-2 (MMP-2) secretion profile of FLS over 12 days of culture. FLS were subjected to continuous, intermittent, and sequential cytokine treatments of interleukin-1 beta (IL-1β), tumour necrosis factor-alpha (TNF-α), and transforming growth factor-beta 1 (TGF-β1). HA was assessed by an enzyme-linked immunosorbent assay (ELISA) for content and agarose gel electrophoresis for molecular weight distribution. Relative lubricin content was determined by western blot. Pro MMP-2 and active MMP-2 were quantified by gelatin zymography. All intermittent and sequential treatments significantly increased secretion of high-molecular-weight (>3 MDa) HA for the duration of the culture. Sequentially treated groups elevated lubricin synthesis, whereas only groups receiving IL-1β and TNF-α for 2 days followed by TGF-β1 for 1 day reduced active MMP-2 to unstimulated control levels. These data provide important information on the long-term functional potential of cytokine-stimulated FLS and suggest that temporal regulation of cytokine exposure can be a powerful tool to guide healthy synovial secretions.
Keywords: cytokine; fibroblast-like synoviocytes; hyaluronic acid; inflammation; secretions; synovial fluid; tissue engineering.
© 2018 John Wiley & Sons, Ltd.
Similar articles
-
Interactive cytokine regulation of synoviocyte lubricant secretion.Tissue Eng Part A. 2010 Apr;16(4):1329-37. doi: 10.1089/ten.TEA.2009.0210. Tissue Eng Part A. 2010. PMID: 19908966 Free PMC article.
-
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.Osteoarthritis Cartilage. 2006 Dec;14(12):1237-47. doi: 10.1016/j.joca.2006.05.009. Epub 2006 Jun 30. Osteoarthritis Cartilage. 2006. PMID: 16806998
-
Interleukin-1β affects the phospholipid biosynthesis of fibroblast-like synoviocytes from human osteoarthritic knee joints.Osteoarthritis Cartilage. 2017 Nov;25(11):1890-1899. doi: 10.1016/j.joca.2017.07.011. Epub 2017 Jul 20. Osteoarthritis Cartilage. 2017. PMID: 28736247
-
The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes.Arthritis Res Ther. 2017 May 8;19(1):89. doi: 10.1186/s13075-017-1301-5. Arthritis Res Ther. 2017. PMID: 28482921 Free PMC article.
-
Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors.Arthritis Rheum. 2007 Aug;56(8):2523-34. doi: 10.1002/art.22829. Arthritis Rheum. 2007. PMID: 17665433
Cited by
-
MOntelukast as a potential CHondroprotective treatment following Anterior cruciate ligament reconstruction (MOCHA Trial): study protocol for a double-blind, randomized, placebo-controlled clinical trial.Trials. 2022 Jan 31;23(1):98. doi: 10.1186/s13063-021-05982-3. Trials. 2022. PMID: 35101085 Free PMC article.
-
Addition of High Molecular Weight Hyaluronic Acid to Fibroblast-Like Stromal Cells Modulates Endogenous Hyaluronic Acid Metabolism and Enhances Proteolytic Processing and Secretion of Versican.Cells. 2020 Jul 13;9(7):1681. doi: 10.3390/cells9071681. Cells. 2020. PMID: 32668663 Free PMC article.
-
The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial.Osteoarthr Cartil Open. 2024 Dec 23;7(1):100563. doi: 10.1016/j.ocarto.2024.100563. eCollection 2025 Mar. Osteoarthr Cartil Open. 2024. PMID: 39867299 Free PMC article.
-
Allogenic Platelet-Rich Plasma for the Treatment of Adhesive Capsulitis.Cureus. 2023 Oct 22;15(10):e47491. doi: 10.7759/cureus.47491. eCollection 2023 Oct. Cureus. 2023. PMID: 38022351 Free PMC article. Review.
-
Dynamic synovial fibroblasts are modulated by NBCn1 as a potential target in rheumatoid arthritis.Exp Mol Med. 2022 Apr;54(4):503-517. doi: 10.1038/s12276-022-00756-6. Epub 2022 Apr 12. Exp Mol Med. 2022. PMID: 35414711 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous